As Cinderellas go, High Point would need about 10 pounds of memory foam to fill Ed DeCourcey’s glass slippers.
National survey of more than 1,100 bladder cancer patients finds nearly 80% report fear of recurrence, rising above 90% among patients under 50; Many respondents report undergoing ...
EL MUNDO on MSN
Trapped in the hell of hypochondria: "I felt like I had Covid, sclerosis, bladder cancer, heart attacks... absolutely everything"
For most people, a headache or a twinge in the side is just a passing concern. However, 4% of the population sees in these discomforts the omen of a grim fate, the beginning of a certain illness. "You ...
Scottsdale leaders approved a program that will provide cancer screenings to local firefighters who are often exposed to numerous carcinogens.
Watch two British men in suits and tuxedos take on the challenge of tasting 'tossed shredded fish maw,' also known as fish bladder. Their priceless reactions, humorous banter, and honest commentary ...
Bladder cancer is often discovered because a person notices blood in their urine. For many patients, this is the first warning sign that something is wrong. Seeing this change usually encourages ...
Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting ...
GlobalData on MSN
J&J reports positive data for Erda-iDRS in bladder cancer
Erda-iDRS delivers erdafitinib into the bladder over three months, enabling localised therapy and reducing systemic exposure.
NCCN now recognizes BCG-unresponsive papillary-only NMIBC as eligible for nogapendekin plus BCG, broadening access beyond the ...
NCCN now includes Anktiva plus BCG for BCG-unresponsive papillary-only NMIBC, acknowledging an unmet need in patients without CIS who have limited post-BCG options. Radical cystectomy remains ...
A new national survey from the Bladder Cancer Advocacy Network (BCAN) finds that many bladder cancer patients still face major gaps in diagnosis, mental health support and financial protection, ...
Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a biological pathway that helps explain why some bladder cancers do not respond well ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results